Citation tools
"LATE-BREAKING ABSTRACT: RESPIRE 1: Ciprofloxacin DPI 32.5mg b.d. administered 14 day on/off or 28 day on/off vs placebo for 48 weeks in subjects with non-cystic fibrosis bronchiectasis (NCFB)." European Respiratory Journal
48.suppl 60
(2016):
OA272.
Web. 28 Mar. 2024.